investorscraft@gmail.com

Intrinsic Value of Abbott Laboratories (ABT)

Previous Close$110.57
Intrinsic Value
Upside potential
Previous Close
$110.57

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %1.3NaN
Revenue, $43653NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m35291NaN
Operating income, $m8362NaN
EBITDA, $m11629NaN
Interest expense (income), $mNaN
Earnings before tax, $m8306NaN
Tax expense, $m1373NaN
Net income, $m6933NaN

BALANCE SHEET

Cash and short-term investments, $m10170NaN
Total assets, $m74438NaN
Adjusted assets (=assets-cash), $m64268NaN
Average production assets, $m43672NaN
Working capital, $m9735NaN
Total debt, $m16773NaN
Total liabilities, $m37533NaN
Total equity, $m36905NaN
Debt-to-equity ratio0.454NaN
Adjusted equity ratio0.451NaN

CASH FLOW

Net income, $m6933NaN
Depreciation, amort., depletion, $m3267NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m9581NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-1777NaN
Free cash flow, $m11358NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m9735
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount